Pro Medicus Delivers Record Profit

18 August 2017; Company Announcement - Full Year Results 2016-2017 - Acrobat pdf 186k Highlights Record after-tax profit of $9.32 million – up 46% Underlying profit after-tax of $9.87 million – up 53% Revenue of $31.62 million – up 15% Margins increase to 45% – up 29% Cash reserves $22.78 million – up 33% Increased final dividend 2.5c per share, fully franked Total dividends for year 4c per share, partially franked Leading health imaging company Pro Medicus Limited [ASX: PME] today announced a record full- year after-tax profit of $9.32 million for the 12 months to 30 June 2017 – a 46% increase on the previous corresponding period. Underlying profit after tax (excluding currency) was $9.87 million – up 53.4%. Revenue for the year grew by 15% to $31.62 million. The company’s cash reserves grew to $22.78 million an increase of 33%. The company remains debt-free. The Board announced a fully-franked final dividend of 2.5c per share, making total dividends for the year 4c per share, partially-franked. Key drivers of the result were strong performances from the company’s North American and Australian divisions, as well as decreased operating expenses all of which contributed to significant margin growth. Pro Medicus CEO, Dr Sam Hupert said, “This was our most successful year by any measure. Net profit rose strongly despite an unrealised currency loss of $544,000. Stripping out currency, underlying profit increased by 53% to $9.87 million. Margins grew by 29% and we think there is headroom in FY18 for further margin growth. We are also delighted to have returned to fully- franked dividends 6 months earlier than previously predicted.” Dr Hupert said both the North American and Australia businesses performed strongly, while Europe was in line with budget.

Dr Sam Hupert | CommSecTV Executive Series

18 May 2017 Dr Sam Hupert, CEO and Co-Founder, Pro Medicus, was recently interviewed by CommSec's Tom Piotrowski, Market Analyst, for the Executive Series on 27 April 2017. In the below video interview, Dr Hupert provides a Pro Medicus update and overview, while also discussing market potential, competitive forces, financial performance and growth opportunities.    

PME Brings Visage 7 Open Archive to North America

18 May 2017; Company Announcement - PME Introduces Visage 7 Open Archive - Acrobat pdf 81k Highlights Built on the same ultrafast, highly scalable enterprise imaging platform used in Visage 7. Modular design based on open standards ensures maximum interoperability even in the most complex environments. Already in use in many large scale implementations outside the U.S. Enables Visage to offer choice of deconstructed or single vendor solutions. Well placed to fill the needs of a rapidly changing North American archive market. Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has introduced Visage 7 Open Archive in North America. Already in use at many large-scale implementations outside the U.S., Visage 7 Open Archive delivers ultrafast access to images and industry-leading scalability all within a modular, open standards framework. “With Visage 7, we’ve set the benchmark when it comes to speed, functionality and scalability,“ said Malte Westerhoff, PhD, Co-founder and Global CTO of Visage Imaging. “The archive is an integral part of an enterprise imaging strategy, so it too must have the necessary performance, interoperability and scalability. We have been able to achieve this with Visage 7 Open Archive by utilising the same enterprise imaging platform that has made Visage 7 so successful, whilst at the same time ensuring that it is open standards based.” Visage 7 Open Archive closely couples the storage of images to Visage 7 to provide performance and interoperability unmatched by others. “Unlike legacy PACS vendors, we have offered a modular or deconstructed solution that provides our clients with the flexibility to choose the technology components that best suits their needs,” said Dr Sam Hupert, Pro Medicus CEO. “To date, we have replaced more than 40

Mercy Completes Visage Implementation in Record Time

20 March 2017; Company Announcement - Mercy Completes Visage Implementation - Acrobat pdf 118k Highlights Mercy completed its enterprise-wide implementation of Pro Medicus’ Visage 7 technology in less than 6 months Mercy uses Visage 7 for primary diagnosis of medical images across 50 Mercy imaging locations, including 43 community and specialty hospitals Mercy is the fifth largest Catholic health system in the U.S., spanning 4 U.S. states Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has completed in record time its enterprise-wide implementation of Visage® 7 technology at Mercy, the fifth largest Catholic health system in America. Visage’s powerful architecture for Mercy processes an impressive 70,000 current and prior imaging exams daily, equating to over 25 million annual studies. Visage 7 has enabled the decommissioning of 9 separate instances of Mercy’s legacy PACS, consolidating diagnostic, clinical and mobile image viewing with one Visage system. Mercy has implemented Visage 7 in a centralized, high-availability architecture providing zero downtime. “Mercy needed to quickly install Visage because we were operating 9 separate imaging systems, and those systems were aging,” explained Gil Hoffman, CIO, Mercy Technology Services. “Visage gave us the support we needed to speed things up, shave months off our plan and get a single, strategic imaging platform in place. Now, only 6 months later, our system architecture is simplified, and physicians across Mercy have faster, more reliable access to images.” “Visage is extremely proud to have completed this very large scale, enterprise implementation in a fraction of the time originally allocated to the project,” said Dr Sam Hupert, CEO of Pro Medicus. “We believe this could well be a first for the industry where traditionally implementations of this scale can

Pro Medicus Limited Signs Five-year RIS Deal with Primary Health Care Limited

14 March 2017; Company Announcement - Primary Health Feb 2017 - Acrobat pdf 180k Highlights Five-year deal with Primary Health Care Limited, one of the largest diagnostic imaging networks in Australia PME to provide Visage RIS to Primary Health Care’s 141 diagnostic imaging sites Will deliver 11% uplift to PME’s FY16 revenue each year for 5 years Transaction-based agreement with potential upside Leading healthcare imaging company Pro Medicus Limited [ASX: PME] today announced it has signed a five-year agreement with Healthcare Imaging Services, the diagnostic imaging division of Primary Health Care Limited [ASX:PRY], one of Australia's leading ASX-listed healthcare companies. The agreement will see Pro Medicus install its Visage RIS (radiology information system) throughout the Healthcare Imaging Services network. The major functions of the RIS software includes patient scheduling, billing and back office practice management functions. Healthcare Imaging Services is one of Australia’s largest diagnostic imaging networks. It comprises 141 diagnostic imaging sites throughout Australia, with operations in New South Wales, ACT, Victoria, South Australia, West Australia and Queensland. The five-year transaction-based agreement is expected to deliver an uplift equivalent to 11% of the Company’s FY16 revenue for each year of the contract. Dr Sam Hupert, CEO of Pro Medicus said, “This is one of the largest RIS deals in Australia, so it is very significant for us. With this contract we will regain our dominant position in the Australian RIS market.” Chief Executive of Healthcare Imaging Services, Dean Lewsam, said: “We undertook an extensive evaluation process before deciding on the Visage RIS from Pro Medicus." “Visage RIS has the functionality and scalability that a large geographically diverse group such as ours requires. We expect a national system will help deliver significant efficiencies across our business.” Implementation is

Pro Medicus Limited Interim Results

17 February 2017  |  Company Announcement Pro Medicus Limited Half Year 2016-17 Results - Acrobat pdf 463k Highlights: After-tax profit of $4.80 million – up 63.1% Revenue of $15.20 million – up 6.4% Underlying profit after tax - $4.08 million – up 44.7% Cash reserves $20.28 million – up $3.17 million in the six-month period Interim dividend of 1.5c per share unfranked Leading health imaging company Pro Medicus Limited [ASX: PME] today announced a first-half after-tax profit of $4.80 million for the six months to 31 December 2016 – 63.1% higher than for the previous corresponding period. Revenue for the six months was $15.20 million – a 6.4% increase on the previous corresponding period. Profit after tax from underlying operations for the half was $4.08 million compared to $2.82 million from the previous corresponding period, an increase of 44.7%. The company's cash reserves were $20.28 million at the end of the period, an increase of $3.17 million for the six-month period. The company remains debt-free and announced an unfranked interim dividend of 1.5c per share. Pro Medicus CEO, Dr Sam Hupert said, “During the period we continued to make significant inroads into the North America market. In July we signed an $18 million six-year contract with Mayo Clinic, one the world’s most recognised health systems, whilst operationally we were extremely busy installing a large number of new Visage 7 sites. Pleasingly, all of these implementations were on, or ahead of schedule.” “Transaction based revenue from our US operation grew strongly as more facilities were brought on line whilst at the same time expenses, as a percentage of revenue, were down. We see these trends continuing in the second half.” The company is looking to build on its presence in

Pro Medicus Limited Full-Year Results

19 August 2016  |  Company Announcement Pro Medicus 2016 Full Year Results - Acrobat pdf 189k Highlights: After-tax profit $6.37 million – up 98% Underlying after-tax profit up 212% Revenue increased to $27.58 million – up 57% Cash reserves $17.1 million - up 32% Final dividend of 1.5c per share unfranked; total for year 3c per share Rapidly expanding footprint in North American market Leading health imaging company Pro Medicus Limited [ASX: PME] today announced a full-year after-tax profit of $6.37 million for the 12 months to 30 June 2016 – a 98% increase on the previous corresponding period. Revenue for the year grew by 57% to $27.58 million. The company's cash reserves grew to $17.1 million an increase of 32%. The company remains debt-free. Directors announced an unfranked final dividend of 1.5c per share, making a total dividend for the year of 3c per share. During the period the company made announcements for contracts with a minimum value of A$60 million including: Allegheny Health Network, USA - Sept 2015, A$11 million five-year contract. German Government Hospital - Nov 2015, A$3 million five-year contract. Mercy Health System - April 2016, A$21 million seven-year contract with the seventh largest Catholic health care system in the USA. Franciscan Missionaries of Our Lady Health System - April 2016, A$7 million, seven-year contract with the largest health system in the US state of Louisiana. Mayo Clinic - July 2016, A$18 million, six-year contract with Mayo Clinic, USA. Key drivers of the company’s profit increase for the year were the significant increase in the performance of the North American operations, supplemented by a capital sale in Europe and a modest increase in Australian sales. As the Group’s costs are relatively fixed, this increase

PharmacySydney.com MJDHealthPharmacy.com
Go to Top